GE HealthCare Says FDA Approves Use of Optison Ultrasound Enhancing Agent in Children

MT Newswires Live

2025/05/13

GE HealthCare Technologies (GEHC) said Tuesday the US Food and Drug Administration has approved a pediatric indication for its Optison ultrasound enhancing agent.

The regulatory approval will help improve the clarity and accuracy of echocardiograms in children to allow cardiologists to diagnose heart conditions, the company said.

Optison was approved for adults in 1997 and this latest approval affirms its safety and efficacy in pediatric patients "of all ages," GE HealthCare said.

Price: 73.93, Change: -0.18, Percent Change: -0.24

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2535577432"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2535577432\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2535577432?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-13 21:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2535577432","market":"sh","top_or_hot":-1,"title":"GE HealthCare Says FDA Approves Use of Optison Ultrasound Enhancing Agent in Children","media":"MT Newswires Live","content":"<html><body><p> GE HealthCare Technologies (GEHC) said Tuesday the US Food and Drug Administration has approved a pediatric indication for its Optison ultrasound enhancing agent.</p><p>The regulatory approval will help improve the clarity and accuracy of echocardiograms in children to allow cardiologists to diagnose heart conditions, the company said.</p><p>Optison was approved for adults in 1997 and this latest approval affirms its safety and efficacy in pediatric patients \"of all ages,\" GE HealthCare said.</p><p>Price: 73.93, Change: -0.18, Percent Change: -0.24</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GE HealthCare Says FDA Approves Use of Optison Ultrasound Enhancing Agent in Children</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGE HealthCare Says FDA Approves Use of Optison Ultrasound Enhancing Agent in Children\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-05-13 21:48</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> GE HealthCare Technologies (GEHC) said Tuesday the US Food and Drug Administration has approved a pediatric indication for its Optison ultrasound enhancing agent.</p><p>The regulatory approval will help improve the clarity and accuracy of echocardiograms in children to allow cardiologists to diagnose heart conditions, the company said.</p><p>Optison was approved for adults in 1997 and this latest approval affirms its safety and efficacy in pediatric patients \"of all ages,\" GE HealthCare said.</p><p>Price: 73.93, Change: -0.18, Percent Change: -0.24</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0124676726.USD","symbol_name":"AB SICAV I - SUSTAINABLE US THEMATIC PORTFOLIO \"A\" (USD) ACC","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2535577432","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2535577432","pubTimestamp":1747144114,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"GE HealthCare Technologies  said Tuesday the US Food and Drug Administration has approved a pediatric indication for its Optison ultrasound enhancing agent.The regulatory approval will help improve the clarity and accuracy of echocardiograms in children to allow cardiologists to diagnose heart conditions, the company said.Optison was approved for adults in 1997 and this latest approval affirms its safety and efficacy in pediatric patients \"of all ages,\" GE HealthCare said.Price: 73.93, Change: -0.18, Percent Change: -0.24","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0124676726.USD":"AB SICAV I - SUSTAINABLE US THEMATIC PORTFOLIO \"A\" (USD) ACC","BK4588":"碎股","LU0689626769.HKD":"AB SICAV I - SUSTAINABLE US THEMATIC PORTFOLIO \"A\" (HKD) ACC","GEHC":"GE HEALTHCARE TECHNOLOGIES INC","BK4585":"ETF&股票定投概念","BK4082":"医疗保健设备","GE":"GE航空航天"},"translate_title":"GE HealthCare称FDA批准Optison超声增强剂用于儿童","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GEHC":0.9,"GE":1},"content_text":"GE HealthCare Technologies (GEHC) said Tuesday the US Food and Drug Administration has approved a pediatric indication for its Optison ultrasound enhancing agent.The regulatory approval will help improve the clarity and accuracy of echocardiograms in children to allow cardiologists to diagnose heart conditions, the company said.Optison was approved for adults in 1997 and this latest approval affirms its safety and efficacy in pediatric patients \"of all ages,\" GE HealthCare said.Price: 73.93, Change: -0.18, Percent Change: -0.24","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}